Nick Evans from BiotechnologyNews.net has just written an article that describes the current situation quite nicely.
While creditors voted for the takeover of Ventracor by Siqro Inc on Friday,the saga does not appear to be over for the Australian heart device company, with the United States buyers yet to come up with bridging finance to close their takeover ofthe troubled company.
While the second creditors meeting voted in favour of the sale, the deal is not certain to close, with Siqro œbelieved to be a holding company for US medical device company Orqis still to source bridging finance to pay for the company‘s operations between now and the expected close of the takeover deal on June 12.
BTN understands that, while the administrators report released to creditors last week showed the US company had at least $US28 million to finance Ventracor‘s operations over the next 12months, negotiations were still ongoing overthe weekend regarding the release of bridging finance to fund the Ventracor wages bill for the next fortnight.
Voluntary administrators Ferrier Hodgson are reported to have told the creditors meeting on Fridaythat the company had only around $500,000 at bank at the end of last week enough to pay the administrators fees, but little else.
As of last night, as BTN understands the situation, Siqro had still not been able to assure Ferrier Hodgson that it had the complete funding package, including bridging finance, in place. This would be the worst possible outcome for Ventracor staff, in particular, as Siqro had indicated it would retain a substantial proportion of the company‘s remaining employees. One shareholder who attended Friday‘s meeting revealed to BTN that administrators told Ventracor staf and shareholders at the creditors meeting that they would have no choice but to send the company into liquidation if agreement on bridging finance was not reached by Monday.
Despite this, BTN understands this did not occur, with Ferier Hodgsons extending the discussions with Siqro for at least another day. The news has given shareholder activists some hope that their eforts to keep the company in Australian hands may not yet be dead.
The Save Ventracor shareholders group was forced to withdraw their own proposed Deed of Company Arangement shortly before Friday‘s creditors meeting, after key cornerstone investors withdrew their support for the bid, citing a lack of time to conduct proper due diligence on Ventracor‘s books.
BTN understands the group has still not given up hope, and has again surveyed shareholders seeking firm cash commitments to a recapitalisation plan, as well as fielding last-minute offers from new potential cornerstone investors.
http://biotechnologynews.net/storyview.asp?storyid=1027746§ionsource=s0
About this news blog
The purpose of this blog is to allow the Ventracor Shareholder's Group to assist in the dissemination and sharing of information, and to allow legitimate debate on the items posted on the blog. No claim is made as to the accuracy or authenticity of the content.
Monday, June 1, 2009
Disclaimer
All are invited to post constructive comments on all blog topics.
The comments on the blog may be monitored, and the Ventracor Shareholder's Group reserves the right not to post or remove or moderate any comments which in its opinionare unlawful, threatening, defamatory, offensive, or obscene.
This "blog" has links to information on other web sites. The opinions expressed in these linked articles are those of the relevant authors.
This "blog" allows anyone from the public to post comments. Any views expressed in these comments are those of the relevant author.
The Ventracor Shareholders Group does not endorse the views or opinions expressed in the linked articles or comments.
The Ventracor Shareholder's Group does not accept any responsibility for any injury, loss or damage incurred by use of or reliance on the information.Anyone who wishes to have a comment or link removed from the website should email contact@saveventracor.com immediately.
The comments on the blog may be monitored, and the Ventracor Shareholder's Group reserves the right not to post or remove or moderate any comments which in its opinionare unlawful, threatening, defamatory, offensive, or obscene.
This "blog" has links to information on other web sites. The opinions expressed in these linked articles are those of the relevant authors.
This "blog" allows anyone from the public to post comments. Any views expressed in these comments are those of the relevant author.
The Ventracor Shareholders Group does not endorse the views or opinions expressed in the linked articles or comments.
The Ventracor Shareholder's Group does not accept any responsibility for any injury, loss or damage incurred by use of or reliance on the information.Anyone who wishes to have a comment or link removed from the website should email contact@saveventracor.com immediately.